Drug developers are gaining more ways to investigate how a medicine might affect people before it enters clinical trials. Human tissues grown in laboratories, devices that reproduce aspects of an ...
Anthropic outlined collaborations with six organizations, including Bristol Myers Squibb, Generate Biomedicines and BigHat ...
The new software, AI Link, connects large language models to laboratory software so that scientists can request broad tasks ...
Labcorp Holdings (NYSE: LH) partnered with Waters Corporation to deploy the BD Onclarity HPV Assay across its national ...
An optimized SNEDDS formulation of flutamide achieved rapid self-emulsification, near-complete drug release, and stronger ...
Agreement complements revenue from standard gene expression and DRP® services- Development and validation services will support a European ...
Functionalizing coumarin with Fe₃O₄ nanoparticles lowered the concentrations needed to inhibit and eradicate ...
The operation led to the arrest of alleged cartel leader Anochili Innocent and three Mexican nationals identified as Juan ...
Charles River Laboratories International (NYSE:CRL) agreed to deploy its Virtual Control Group database for Ipsen to support ...
Backed by an ₹86 crore government grant and ₹70 crore Series A funding, Peptris Technologies is leveraging generative AI to ...
Anthropic bought Mithril Medicine, a one-person biotech that ran a drug program with Claude, a sign its market may reach ...
Celularity Inc. announced an exclusive manufacturing and commercial collaboration with Vesalius Longevity Labs Inc. on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results